Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Recombinant human bone morphogenetic protein-2: adverse events reported to the Manufacturer and User Facility Device Experience database.

Woo EJ.

Spine J. 2012 Oct;12(10):894-9. doi: 10.1016/j.spinee.2012.09.052. Epub 2012 Oct 22.

PMID:
23098616
2.

A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned.

Carragee EJ, Hurwitz EL, Weiner BK.

Spine J. 2011 Jun;11(6):471-91. doi: 10.1016/j.spinee.2011.04.023. Review.

PMID:
21729796
3.

Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery.

Tannoury CA, An HS.

Spine J. 2014 Mar 1;14(3):552-9. doi: 10.1016/j.spinee.2013.08.060. Epub 2014 Jan 8. Review.

PMID:
24412416
4.

Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis.

Fu R, Selph S, McDonagh M, Peterson K, Tiwari A, Chou R, Helfand M.

Ann Intern Med. 2013 Jun 18;158(12):890-902. doi: 10.7326/0003-4819-158-12-201306180-00006. Review.

PMID:
23778906
5.

Safety profile for the clinical use of bone morphogenetic proteins in the spine.

Poynton AR, Lane JM.

Spine (Phila Pa 1976). 2002 Aug 15;27(16 Suppl 1):S40-8. Review.

PMID:
12205419
6.

Bone morphogenetic protein-2 and spinal arthrodesis: the basic science perspective on protein interaction with the nervous system.

Dmitriev AE, Lehman RA Jr, Symes AJ.

Spine J. 2011 Jun;11(6):500-5. doi: 10.1016/j.spinee.2011.05.002. Review.

PMID:
21729799
7.

Occipitocervical fusion using recombinant human bone morphogenetic protein-2: adverse effects due to tissue swelling and seroma.

Shahlaie K, Kim KD.

Spine (Phila Pa 1976). 2008 Oct 1;33(21):2361-6. doi: 10.1097/BRS.0b013e318183971d. Review.

PMID:
18827703
8.

Topical bovine thrombin: a 21-year review of topical bovine thrombin spontaneous case safety reports submitted to FDA's Adverse Event Reporting System.

Clark JA, Humphries JE, Crean S, Reynolds MW.

Pharmacoepidemiol Drug Saf. 2010 Feb;19(2):107-14. doi: 10.1002/pds.1874. Review.

PMID:
20014051
9.

Adjustable silicone gastric banding adverse events reported to the Food and Drug Administration.

Brown SL, Reid MH, Duggirala HJ.

J Long Term Eff Med Implants. 2003;13(6):509-17. Review.

PMID:
15056068
10.

Quality assessment of spontaneous triggered adverse event reports received by the Food and Drug Administration.

Brajovic S, Piazza-Hepp T, Swartz L, Dal Pan G.

Pharmacoepidemiol Drug Saf. 2012 Jun;21(6):565-70; discussion 571-2. doi: 10.1002/pds.3223. Epub 2012 Feb 22. Review.

PMID:
22359404
11.
12.

Bone morphogenetic protein use in spine surgery-complications and outcomes: a systematic review.

Faundez A, Tournier C, Garcia M, Aunoble S, Le Huec JC.

Int Orthop. 2016 Jun;40(6):1309-19. doi: 10.1007/s00264-016-3149-8. Epub 2016 Mar 10. Review.

PMID:
26961193
13.

Trocar-associated injuries and fatalities: an analysis of 1399 reports to the FDA.

Fuller J, Ashar BS, Carey-Corrado J.

J Minim Invasive Gynecol. 2005 Jul-Aug;12(4):302-7. Review.

PMID:
16036187
14.

Bone morphogenetic proteins and spinal surgery.

Sandhu HS.

Spine (Phila Pa 1976). 2003 Aug 1;28(15 Suppl):S64-73. Review.

PMID:
12897477
15.

Safety and Procedural Success of Left Atrial Appendage Exclusion With the Lariat Device: A Systematic Review of Published Reports and Analytic Review of the FDA MAUDE Database.

Chatterjee S, Herrmann HC, Wilensky RL, Hirshfeld J, McCormick D, Frankel DS, Yeh RW, Armstrong EJ, Kumbhani DJ, Giri J.

JAMA Intern Med. 2015 Jul;175(7):1104-9. doi: 10.1001/jamainternmed.2015.1513. Review.

PMID:
25938303
16.
17.

Postmarketing safety of biologics and biological devices.

Woo EJ.

Spine J. 2014 Mar 1;14(3):560-5. doi: 10.1016/j.spinee.2013.09.056. Epub 2013 Dec 14. Review.

PMID:
24342704
18.

Results from the first decade of research conducted by the Research on Adverse Drug Events and Reports (RADAR) project.

McKoy JM, Fisher MJ, Courtney DM, Raisch DW, Edwards BJ, Scheetz MH, Belknap SM, Trifilio SM, Samaras AT, Liebling DB, Nardone B, Tulas KM, West DP.

Drug Saf. 2013 May;36(5):335-47. doi: 10.1007/s40264-013-0042-x. Review.

19.

Instrument Failures for the da Vinci Surgical System: a Food and Drug Administration MAUDE Database Study.

Friedman DC, Lendvay TS, Hannaford B.

Surg Endosc. 2013 May;27(5):1503-8. doi: 10.1007/s00464-012-2659-8. Epub 2012 Dec 14. Review.

PMID:
23242487
20.

Complications of Electromechanical Morcellation Reported in the Manufacturer and User Facility Device Experience (MAUDE) Database.

Naumann RW, Brown J.

J Minim Invasive Gynecol. 2015 Sep-Oct;22(6):1018-21. doi: 10.1016/j.jmig.2015.05.008. Epub 2015 May 16. Review.

PMID:
25987522
Items per page

Supplemental Content

Write to the Help Desk